Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · IEX Real-Time Price · USD
4.500
+0.350 (8.43%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Kiora Pharmaceuticals Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for KPRX stock have an average target of 18, which predicts an increase of 300.00% from the current stock price of 4.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 20, 2024.
Analyst Ratings
The average analyst rating for KPRX stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +300.00% | May 20, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 | Strong Buy | Maintains | $18 | +300.00% | Mar 27, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $32 → $18 | Strong Buy | Maintains | $32 → $18 | +300.00% | Feb 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +600.00% | Nov 13, 2023 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $18 → $32 | Strong Buy | Maintains | $18 → $32 | +600.00% | Nov 6, 2023 |
Financial Forecast
Revenue This Year
16.83M
Revenue Next Year
3.06M
from 16.83M
Decreased by -81.82%
EPS This Year
0.95
from -24.21
EPS Next Year
-2.75
from 0.95
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 18.4M | 6.3M | 1.6M | n/a | 23.9M |
Avg | 16.8M | 3.1M | 765,000 | n/a | 19.1M |
Low | 15.7M | n/a | n/a | n/a | 14.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | -62.6% | -48.5% | - | - |
Avg | - | -81.8% | -75.0% | - | - |
Low | - | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.42 | -2.55 | -1.70 | -1.42 | -0.38 |
Avg | 0.95 | -2.75 | -2.25 | -1.38 | -0.37 |
Low | 0.53 | -3.00 | -2.73 | -1.32 | -0.35 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.